Capital Market Strategies LLC has taken a significant step in revising its portfolio by selling 4,000 shares of The Home Depot. This move comes in the second quarter, marking a 70.3% decrease in its stake of the home improvement retailer’s stock.

Capital Market Strategies LLC has reshaped its investment in Chevron, cutting its shares by 3.6% in the second quarter. The firm’s recent SEC filing sheds light on what prompted the decision.

Capital Market Strategies LLC has lowered its holdings in Meta Platforms, Inc. by 13.3% in the second quarter, according to the firm’s SEC filing. The sale of 161 shares leaves the company with 1,048 shares, a stake valued at $774,000.

First Financial Bank Trust Division has added Tesla shares to its investment portfolio, purchasing 1,744 shares in the second quarter. This move, valued at approximately $554,000, underscores Tesla’s continued appeal among institutional investors.

Central Pacific Bank Trust Division has disclosed a 1.5% increase in its CVS Health holdings, adding 500 shares during the second quarter. This move, revealed in the latest SEC filing, brings the institutional investor’s total position to 33,000 shares of the pharmacy giant.

Pensionfund Sabic has reduced its McKesson Corporation holdings by nearly a quarter, selling 900 shares and retaining 2,750. The move was disclosed in the firm’s latest filing with the Securities & Exchange Commission, capturing the attention of investors tracking institutional strategies.

Pensionfund Sabic reduced its stake in Otis Worldwide Corporation by 15.2%, selling 2,500 shares during the first quarter. The institutional investor now holds 14,000 shares, according to a recent SEC filing.

City Center Advisors LLC has acquired a new position in semiconductor firm Rambus, totaling 4,110 shares valued at $263,000. The investment was disclosed in a Securities & Exchange Commission filing and took place in the second quarter.

McLean Asset Management Corp purchased 1,878 shares of Shopify, valued at roughly $215,000, during the second quarter this year. An SEC filing revealed the investment, underscoring continuing institutional interest in the e-commerce software maker.

Key Colony Management LLC has increased its position in Evolv Technologies by 2.0%, acquiring an additional 62,000 shares in the NASDAQ-listed firm. The move brings the fund’s total share count to 3,105,000 and solidifies Evolv as its third largest holding, accounting for approximately 21.9% of its portfolio.

Jacobi Capital Management LLC raised its position in Portland General Electric Company by 33.3% during the first quarter, bringing its total share count to 16,762. With an additional 4,191 shares acquired, the firm’s overall investment is now valued at $748,000—underscoring continued interest in the utility sector.

Advisors Capital Management LLC recently reduced its stake in the Vanguard Extended Market ETF by 5.7%, selling 265 shares in the first quarter. According to a 13F filing with the Securities and Exchange Commission, the firm now holds 4,350 shares of the fund, underscoring a modest recalibration of its institutional portfolio.

Strs Ohio has acquired 358,950 shares of Newmont Corporation, bringing a $17.3 million investment into the basic materials giant. The recent SEC filing highlights the fund’s growing interest in a key mining industry player, alongside other institutional investors and hedge funds.

Kera Capital Partners Inc. recently invested $458,000 in Lockheed Martin Corporation, acquiring 988 shares in the second quarter. The news, disclosed in a filing with the Securities and Exchange Commission, points to growing institutional interest in the leading aerospace company.

Wedbush analysts have lowered their 2029 earnings projection for Revolution Medicines, Inc. (NASDAQ: RVMD) from $1.47 to $1.23 per share. The updated report signals a more reserved stance on the biotech firm’s long-term performance outlook.

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) has seen its projected earnings for 2026 revised downward. According to Leerink Partnrs’ recent report, the biotech company’s EPS forecast now stands at ($4.05) for fiscal year 2026.

Cantor Fitzgerald has revised its earnings projection for United Therapeutics, raising the biotechnology firm’s estimated 2025 earnings to $28.70 per share. The announcement points to growing confidence in the company’s potential for continued expansion.

Roth Capital analysts anticipate that Firefly Aerospace (NASDAQ: FLY) will see a loss of ($0.41) per share in the second quarter of 2025. The forecast, released on September 9th, underscores key challenges for the up-and-coming spaceflight company.

The Rosen Law Firm is urging current and former investors of Simulations Plus, Inc. to inquire about a potential securities class action. The announcement, released on September 12, 2025, suggests there may be legal implications affecting shareholders.

UBS reaffirmed its “Sell” rating on National Beverage, citing ongoing volume concerns. The rating signals the investment bank’s caution about the company’s performance prospects.

Kroger’s stock remains on steady ground with UBS opting to maintain its Neutral assessment. The investment bank points to the grocery chain’s improved execution, though it does not yet advocate a more bullish outlook.